ArticleFrontiers in medicine2025
A robust stacked neural network approach for early and accurate breast cancer diagnosis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Timely and accurate diagnosis of breast cancer remains a critical clinical challenge. In this study, we propose Stacked Artificial Neural Network (StackANN), a robust stacking ensemble framework that integrates six classical machine learning classifiers with an Artificial Neural Network (ANN) meta-learner to enhance diagnostic precision and generalization. By incorporating the Synthetic Minority Over-Sampling Technique (SMOTE) to address class imbalance and employing SHapley Additive exPlanations (SHAP) for model interpretability. StackANN was comprehensively evaluated on Wisconsin Diagnostic Breast Cancer (WDBC) datasets, Ljubljana Breast Cancer (LBC) datasets and Wisconsin Breast Cancer Dataset (WBCD), as well as the METABRIC2 dataset for multi-subtype classification. Experimental results demonstrate that StackANN consistently outperforms individual classifiers and existing hybrid models, achieving near-perfect Recall and Area Under the Curve (AUC) values while maintaining balanced overall performance. Importantly, feature attribution analysis confirmed strong alignment with clinical diagnostic criteria, emphasizing tumor malignancy, size, and morphology as key determinants. These findings highlight StackANN as a reliable, interpretable, and clinically relevant tool with significant potential for early screening, subtype classification, and personalized treatment planning in breast cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.